Clinical Report: Advancements in Understanding Quercetin's Role in Maternal-Fetal Infection Management
Overview
This report reviews the potential of quercetin in managing maternal-fetal infections, highlighting its mechanisms of action and safety during pregnancy.
Background
Infections during pregnancy pose significant risks to both maternal and fetal health, contributing to adverse outcomes such as miscarriage and preeclampsia. Current treatments primarily rely on antibiotics, which have limitations including drug resistance and potential teratogenic effects.
Data Highlights
No numerical data available in the source material.
Key Findings
Quercetin regulates the function of decidual immune cells at the maternal-fetal interface.
It balances the cytokine network, which is crucial for immune tolerance and pathogen defense.
Quercetin targets pathogenic signaling pathways that could disrupt pregnancy.
It enhances the barrier function of trophoblast and decidual stromal cells.
The safety of quercetin during pregnancy has been discussed.
Clinical Implications
Further research is needed to establish quercetin's efficacy and safety profile in clinical settings.
Conclusion
Quercetin presents a promising avenue for the prevention and treatment of infection-related complications in pregnancy, warranting further investigation into its clinical applications.
